Haemonetics (HAE) EBITDA Margin Growth (3y) (2012 - 2026)
Haemonetics (HAE) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,505.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -763.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -184.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn | -1,823.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -1,823.00 |
| Dec 27, 2025 | 571.00 |
| Sep 27, 2025 | 216.00 |
| Jun 28, 2025 | 499.00 |
| Mar 29, 2025 | 1,433.00 |
| Dec 28, 2024 | 321.00 |
| Sep 28, 2024 | 475.00 |
| Jun 29, 2024 | 1,122.00 |
| Mar 30, 2024 | 1,813.00 |
| Dec 30, 2023 | -314.00 |
| Sep 30, 2023 | -1,696.00 |
| Jul 1, 2023 | 1,125.00 |
| Apr 1, 2023 | 68.00 |
| Dec 31, 2022 | -162.00 |
| Oct 1, 2022 | -398.00 |
| Jul 2, 2022 | 1,735.00 |
| Apr 2, 2022 | -232.00 |
| Jan 1, 2022 | 228.00 |
| Oct 2, 2021 | -58.00 |
| Jul 3, 2021 | -170.00 |